Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Apr 3, 2013

5229_dirs_2013-04-03_30419c34-286a-4f30-a6c0-e7f8dbe65c4c.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4984B

AstraZeneca PLC

03 April 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 30 March 2013, the interest of Dr Briggs Morrison, a person discharging managerial responsibilities, in the American Depositary Shares (ADSs) of AstraZeneca PLC changed as detailed below.  One ADS equals one Ordinary Share.

The change in interest relates to the vesting of an award of 24,723 shares made in March 2012 under the AstraZeneca Restricted Share Plan. In accordance with the terms of the award, Dr Morrison has become beneficially entitled to these shares.

Following certain tax deductions, Dr Morrison has received 14,339 shares into a personal brokerage account.

For tax purposes, the fair market value of the shares at vest was $49.98 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

A C N Kemp

Company Secretary

3 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUOVOROWASRAR